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A portable microfluidic system for rapid
measurement of the erythrocyte sedimentation
rate
Ziya Isiksacan,a Ozcan Erelb and Caglar Elbuken*a
The erythrocyte sedimentation rate (ESR) is a frequently used 30 min or 60 min clinical test for screening of
several inflammatory conditions, infections, trauma, and malignant diseases, as well as non-inflammatory
conditions including prostate cancer and stroke. Erythrocyte aggregation (EA) is a physiological process where
erythrocytes form face-to-face linear structures, called rouleaux, at stasis or low shear rates. In this work, we
proposed a method for ESR measurement from EA. We developed a microfluidic opto-electro-mechanical
system, using which we experimentally showed a significant correlation (R2 = 0.86) between ESR and EA. The
microfluidic system was shown to measure ESR from EA using fingerprick blood in 2 min. 40 μl of whole
blood is filled in a disposable polycarbonate cartridge which is illuminated with a near infrared emitting diode.
Erythrocytes were disaggregated under the effect of a mechanical shear force using a solenoid pinch valve.
Following complete disaggregation, transmitted light through the cartridge was measured using a photode-
tector for 1.5 min. The intensity level is at its lowest at complete disaggregation and highest at complete ag-
gregation. We calculated ESR from the transmitted signal profile. We also developed another microfluidic
cartridge specifically for monitoring the EA process in real-time during ESR measurement. The presented
system is suitable for ultrafast, low-cost, and low-sample volume measurement of ESR at the point-of-care.
Introduction
The erythrocyte sedimentation rate (ESR), discovered in 18971
and widely accepted in 1918,2 is a simple clinical test com-
monly used as a sickness index for monitoring several inflam-
matory diseases such as temporal arteritis3,4 and polymyalgia
rheumatica.5–8 It is also accepted as a critical prognostic fac-
tor in some non-inflammatory conditions including stroke,9
heart attack,10 and prostate cancer.11 ESR reflects the rate of
settling of erythrocytes in a vertically placed tube filled with
whole blood. The erythrocyte-free plasma height at the top of
the tube is measured after 30 or 60 min and reported as the
ESR value in mm h−1. The Westergren method is the gold
standard method for ESR measurements, in which a tube
with a length of 300 mm and an inner diameter of 2.55 mm
is used which requires 5 ml of whole blood sample.12,13
Erythrocytes form 3D aggregates that resemble rolls of
coins at stasis or at low shear rates in plasma or an appropri-
ate suspending medium.14–16 This reversible process is the
main factor for the non-Newtonian nature of blood, and as
such, plays a critical role for blood flow.17–19 EA is affected by
(i) intrinsic cellular properties (membrane deformability and
surface charge density),20–22 (ii) suspending medium proper-
ties (fibrinogen concentration in plasma or aggregation-
inducer macromolecule concentration such as dextran),23–28
and (iii) shear forces on cells.29–31 EA is of clinical impor-
tance for diseases such as sepsis, thrombosis, and circulatory
diseases.16,32,33 Most studies utilize aggregometers that mea-
sure EA using photometric methods that quantify the light
beam reflected from or transmitted through a blood sample
during the aggregation process.31,34–40 These aggregometers
differ from each other based on their mechanical unit, which
creates the shear force required for disaggregation. Image
analysis of EA under different dynamic conditions and com-
putational analysis have also been employed for the quantifi-
cation of EA.41–44 Custom-made optical systems (microscopes
and holograms) are also proposed for erythrocyte analysis.
These systems carry out non-invasive single cell investigation
such as measurement of morphological properties, volume,
and refractive index based on interferometric methods.45–48
Due to the complexities of the optical systems and image re-
trieval algorithms, these systems are impractical for rapid
and facile monitoring and quantification of the fast aggrega-
tion process.49
Lab-on-a-chip technologies for blood analysis and their
commercialization possess significant potential for
healthcare.50,51 There are studies that led to benchtop
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commercial products, which measure ESR from aggregation
dynamics.52,53 They work much faster than the Westergren
method (∼5 min) and use smaller sample volumes (∼150 μl).
These products function as photometric rheoscopes,53 how-
ever the detailed working principles of these products are not
disclosed. Therefore, it is not possible to evaluate the under-
lying fundamental phenomena that form the basis of faster
ESR measurements claimed in these devices. In this work, we
aim at explaining the fundamental relationship between EA
and ESR by developing a portable microfluidic system and vi-
sualizing the whole disaggregation/aggregation process and
correlating it with the corresponding optical transmitted
signal.
We measured the rate of EA and used it to predict ESR,
leveraging the relationship between particle size and sedi-
mentation rate. Particle sedimentation in a suspending me-
dium is explained by Stokes' law, which states that the sedi-
mentation velocity of a spherical particle is proportional to
the square of its radius.54 EA forms clusters of erythrocytes,
which have a higher sedimentation velocity than individual
erythrocytes. We explored this direct relationship between
erythrocyte aggregates and their settling velocity in order to
perform rapid ESR measurements from EA.
Herein, we report a microfluidic system that measures
ESR from EA using only 40 μl of whole blood in 2 min. The
system consists of a disposable single-channel polycarbonate
cartridge and a handheld opto-electro-mechanical analyzer.
The test cycle starts off by completely disaggregating erythro-
cytes in the cartridge using a rigorous back and forth fluid
motion generated by a solenoid pinch valve. Then, the fluid
motion is ceased, and cells start to aggregate. During this ag-
gregation phase, near infrared light (λ = 830 nm) optically
transmitted through the cartridge is measured for 1.5 min.
Then, the ESR value is calculated using the optical signal
change. For experimental verification of the microfluidic sys-
tem and the measurement method, whole blood samples of
70 patients were tested with our system. The microfluidic sys-
tem was shown to correlate with the conventional Westergren
method with R2 = 0.86 using linear regression. This value is
higher than the correlation coefficients of commercially avail-
able ESR analyzers.53,55,56 In addition, we integrated a camera
to the system and designed a new cartridge including a sec-
tion for visual observation of the EA process in real-time dur-
ing ESR measurement. Using this unique cartridge, we were
able to demonstrate the one-to-one correspondence between
the aggregation of erythrocytes and the optical transmission
signal. This microfluidic system is of high value for ultrafast




For blood samples, ethical approvals were obtained from the
Ethics Committee of Yildirim Beyazit University Medical
School, Ankara, Turkey and the Ethics Committee of Bilkent
University, Ankara, Turkey. Prior informed consent was taken
from the donors involved in the study. For clinical measure-
ment of ESR, whole blood was used without any pre-
processing of the blood sample. Therefore, for ESR measure-
ments, 5 ml of fresh venous blood was acquired from 70 vol-
unteers at Yildirim Beyazit University Ankara Ataturk Hospi-
tal into vacuum tubes containing ethylenediaminetetraacetic
acid (EDTA; 1.5 mg ml−1) to prevent coagulation. For visual
observation of erythrocytes, pre-processing of whole blood
was needed, which consisted of PBS washing, dilution, and
dextran addition. Therefore, for EA monitoring, 5 ml of fresh
blood was acquired from a healthy male volunteer at Bilkent
University Health Center (Ankara, Turkey) into a vacuum tube
containing EDTA. The blood was centrifuged three times at
3500 rpm for 4 min, and plasma was replaced with 1×
phosphate-buffer saline (PBS) solution each time. A micro-
centrifuge tube was filled with 5 μl of the plasma-free blood
sample and 125 μl of PBS and mixed. Then, 1 mg of 150 kDa
dextran (Sigma-Aldrich) was added to the tube and dissolved
by gentle mixing for 1 min using a pipette.
Particle sedimentation theory
Stokes' law54 governs the settling velocity of a spherical parti-
cle suspended in a medium, where three forces act on the
particle: gravitational (Fg), buoyant (Fb), and drag (Fd) forces.
Each can be written as follows:
Fg = ρparticleVg (1)
Fb = ρmediumVg (2)
Fd = 6πμrϑ (3)
where ρ is the density, V is the particle volume, g is the gravi-
tational acceleration, μ is the medium dynamic viscosity, r is
the particle radius, and ϑ is the particle settling (termination)
velocity. In a stationary system, no other force is effective on
the system, thus yielding:
Fg = Fb + Fd (4)
Plugging eqn (1)–(3) into eqn (4), the particle velocity can
be found as follows:
(5)
For non-spherical particles, a correction factor called the
dynamic shape factor, K, is applied to the drag force in eqn
(3), yielding:
Fnonsphericald = 6πμreϑK (6)
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where re is the equivalent volume radius for a spherical parti-
cle that has the same volume as the non-spherical particle.57
By plugging eqn (1), (2) and (6) into eqn (4), the settling veloc-
ity valid for non-spherical particles can be found as follows:
(7)
According to eqn (5) and (7), one can conclude that the
sedimentation velocity of a particle in a medium is propor-
tional to the square of the size of the particle.
Cartridge designs
Disposable cartridges used in this work were fabricated out
of polycarbonate (PC), a transparent thermoplastic polymer.
Although the use of PDMS microchannels is common in the
microfluidic community, we did not use PDMS since it can
absorb the blood sample and introduce bias to the optical
measurements.58 The channel designs were made in 2D
using CAD software (Autodesk, AutoCAD 2016). The car-
tridges were manufactured using CNC machining. We had
two different cartridge designs. (i) For ESR measurements,
cartridge-1 was used, which has a 1 mm deep, 1 mm wide,
and 50 mm long channel. (ii) For simultaneous ESR measure-
ment and EA monitoring, cartridge-2 was used, which has a
single inlet and outlet and composed of two sections: a deep
section (h1 = 1 mm) for ESR measurement and a shallow sec-
tion (h2 = 150 μm) for EA monitoring.
The relationship between the erythrocyte settling velocity
and erythrocyte aggregation is based on the Stokes' law,
which is a fundamental equation in fluid mechanics. There
are also commercial benchtop instruments that report ESR
values within minutes using EA. However, in the literature,
there are strong oppositions to the use of these devices, since
ensuring complete disaggregation of the erythrocytes is criti-
cal for correlating EA and ESR. Therefore, it is of utmost im-
portance to visualize the behavior of erythrocytes during the
whole process and correlate it with the optical signal.
Cartridge-2 was specifically designed for this purpose. For
the optical transmission signal, the system requires a strong
interaction between the incident light and the erythrocytes;
therefore, the optical path length should be increased using
a deep channel. However, monitoring of individual erythro-
cytes is not possible in a deep microchannel due to the high
population of erythrocytes. The visualization system requires
a smear-like blood sample. Cartridge-2, which is shown in
Fig. 1a, accommodates both of these microchannel segments:
a shallow channel for monitoring of individual erythrocytes
and a deep channel for optical measurement. However,
changing the channel depth changes the wall shear rate as
well as the disaggregating force on erythrocytes. Therefore,
the width of the shallow channel is increased in order to en-
sure that the same wall shear rate is experienced in both
channel segments as described below.
According to Weissenberg–Rabinowitsch–Mooney equa-
tion,59 the wall shear rate (γ) is calculated as
(8)
where Q is the volumetric flow rate, w is channel width, and
h is channel height. Since volumetric flow rate is the same in
the deep and shallow channel segments, the following condi-
tion needs to be met for erythrocytes to experience the same
disaggregating shear rates in both channel segments in order




The channel heights were set as hdeep = 1 mm and hshallow
= 150 μm. The widths for both sections were set as wdeep = 1
mm and wshallow = 44.5 mm, satisfying eqn (9). The lengths
were chosen as Ldeep = 50 mm, and Lshallow = 7.5 mm. The
length of the deep channel segment (50 mm) is the same as
the length of cartridge-1.
Microfluidic measurement system
We developed a microfluidic measurement system that opti-
cally measures the rate of EA and calculates ESR from EA.
Fig. 1a shows the schematic representation of the whole sys-
tem that contains a disposable polycarbonate cartridge and a
handheld analyzer. Two different cartridges were designed
for the experiments. An acrylic cartridge holder was also fab-
ricated in which the cartridges are secured tightly to prevent
any vibration during the measurements. The holder also con-
tains a tygon tubing system, one end of which seals the car-
tridge outlet port when the cartridge is inserted to the holder.
Cartridge-1, which contains a deep single channel (1 mm
wide, 1 mm high), was fabricated for the optical measure-
ment of ESR, since a dense population of erythrocytes was re-
quired for stronger interaction of the cells with the incident
light in order to obtain satisfactory signal change on the
photodetector. Cartridge-2 consists of deep (1 mm wide, 1
mm high) and shallow (44.5 mm wide, 150 μm high) sec-
tions; the latter was designed for real-time observation of the
erythrocytes during the whole test cycle. The opto-electro-
mechanical analyzer which is shown in Fig. 1b consists of
three units: (i) a mixing unit, (ii) an optical unit, and (iii) an
electronic control unit. For the mixing unit, a solenoid pinch
valve (EW-98302-02, Cole-Parmer) is employed to provide con-
tinuous rigorous back and forth blood sample movement in
the cartridge for 15 s. The pinch valve stroke distance (5 mm)
is adjusted so that the shear rate applied by the valve on the
erythrocytes is above the critical shear rate (γcritical) for com-
plete erythrocyte disaggregation. The measurement principle
of the system is based on the analysis of optically transmitted
light through the blood sample which is schematically shown
in Fig. 1c. In the optical unit, a near infrared (NIR) light-
emitting diode (LED) with an 830 nm wavelength and a NIR
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photodetector are employed. The NIR band is chosen to min-
imize the absorption of light by the erythrocytes,16 which in
turn increases the light scattering from and transmission
through the blood sample.60 The LED (VSMG2700, Vishay) is
placed at the top surface of the cartridge and illuminated the
blood-filled channel. Light that passes through the channel
is collected on the photodetector (VEMT4700, Vishay) located
at the bottom of the cartridge. In the electronic control unit,
a custom-designed electronic circuitry and a microprocessor
(IOIO-OTG, SparkFun) are used. The electronic circuitry con-
trols the pumping action and the optical unit. The former cir-
cuit is a single transistor (BD139 NPN, STMicroelectronics)
employed as a switch and controlled by the microcontroller
such that the solenoid valve is activated 15 times during the
15 s disaggregation phase. The detection circuit consists of a
transimpedance amplifier connected to the phototransistor
output, followed by a low-pass filter. The system is controlled
through a computer user interface that can be used to adjust
the intensity of LED, mixing time, and total analysis time.
Cartridge-1 takes 40 μl of a whole blood sample, and
cartridge-2 takes 200 μl of a pre-processed blood sample.
Upon the sample introduction into the cartridge, the test cy-
cle was started by completely disaggregating the erythrocytes
for 15 s using the pinch valve. Then, the valve was turned off,
allowing the cells to re-aggregate. During the aggregation pro-
cess, the sample was illuminated with the LED, and transmit-
ted light was measured by the photodetector. Within the
channel, each individual erythrocyte acts as a scattering cen-
ter.16,48 Since the individual erythrocyte population is high,
the intensity level is at its lowest when the cells are
completely disaggregated (Fig. 1c). On the other hand, the
intensity level reaches its maximum at complete aggregation.
Between the min and max values, as cells aggregate, the
intensity level increases. The transmitted signal was recorded
for 90 s. The amplitude of the transmitted signal, which is
the difference between the signal level at the 90th s and the
signal level at the start of the aggregation process, was calcu-
lated using Matlab (R2014, MathWorks) and recorded as the
aggregation index (AI). The results are verified using the mea-
surements performed using the conventional Westergren
method shown in Fig. 1d. For real-time observation of the EA
process, the shallow section is monitored using a 40× micro-
scope objective (Axio Vert.A1, Zeiss) coupled to a camera
(Axiocam ICc 1, Zeiss).
Fig. 1 The microfluidic system for ultrafast ESR measurement and EA monitoring. (a) Schematic representation of the system and the method. A
pinch valve disaggregates erythrocytes in whole blood, and a photodetector collects optically transmitted light for ESR measurement. An optical
microscope and a camera set-up allow real-time monitoring of the aggregation process. (b) The hand-held and portable microfluidic system de-
veloped for ESR measurement at the point-of-care. (c) Typical transmitted signal intensity versus time curve obtained from the microfluidic system
during ESR measurement. The minimum intensity corresponds to complete disaggregation and the maximum intensity corresponds to complete
aggregation. Between these intervals, aggregation occurs. (d) The Westergren method which is used for conventional ESR measurements.
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Results and discussion
Quantifying the aggregation of erythrocytes
The microfluidic system records optically transmitted light
through the blood sample. The minimum intensity of light
indicates complete disaggregation of the cells. During the ag-
gregation process, the intensity level increases as shown in
Fig. 2. To quantify the aggregation of erythrocytes, two aggre-
gation indices (AI1 and AI2) were calculated. AI1 is the area
under the curve (A) divided by the total area (A + B) of the
transmitted signal, whereas AI2 is the amplitude (AMP) that
corresponds to the change of the transmitted signal.16 The
total analysis time is another parameter to be considered. We
have calculated AI1 and AI2 for a series of analysis durations
from 30 s to 120 s. Fig. 2a shows the transmitted signal
intensities of four whole blood samples with different ESR
values (11 mm h−1, 16 mm h−1, 33 mm h−1, and 54 mm h−1)
measured using the Westergren method. The samples were
chosen such that two samples were in the normal ESR range
(0 mm h−1 ≤ ESR ≤ 30 mm h−1), and the other two were in
the clinical ESR range (ESR > 30 mm h−1). The signals were
recorded for 120 s after complete disaggregation. For each
test, the two aggregation indices were calculated for different
assay times (30, 36, 42,… 120 s). Using the two aggregation
indices defined above, in total, 32 AI values were calculated.
Then, for each of the 32 AIs, the parity plot was obtained
using the ESR values measured by the 30 min Westergren
method (W 30) and the AI of interest. For each curve, the
goodness of the fit (R2) was calculated. Fig. 2b and c give the
goodness of fit of AI1 and AI2, respectively, measured for dif-
ferent analysis durations. As seen in Fig. 2, R2 for AI1 differs
significantly for different test durations whereas R2 for AI2 is
consistent and has a value closer to 1 at all assay times.
ESR measurement with the microfluidic system
After determining the aggregation index that has the highest
correlation with the conventional ESR method, whole blood
samples of 70 volunteers were tested with the microfluidic
system and compared with the measurements obtained by
the gold standard method. Attention was paid in order to
span a wide dynamic range covering both the healthy and
clinical ESR ranges. The ESR values of the samples were first
measured using the automated ESR analyzer (Linear
Chemicals, Autoanalyzer) employing the 30 min Westergren
ESR method within 1 h of venipuncture. Upon the measure-
ment with the analyzer, 40 μl of whole blood was withdrawn
from each Westergren tube and tested with the microfluidic
system at room temperature (24 °C). AI2 measured at the
90th s was chosen as the basis for the microfluidic ESR
method. This value was calculated from the transmitted sig-
nal intensity of each volunteer sample. The regression analy-
sis of the measurements is shown in Fig. 3, where the y-axis
is the conventionally measured ESR values of the 70 volun-
teers, and the x-axis is the calculated aggregation indices cor-
responding to each sample's optical transmission signal as
shown in Fig. 3. The overall correlation coefficient (R2) of the
regression curve is 0.86. The correlation coefficient (R2) is
0.79 in the normal ESR range (0 mm h−1 ≤ ESR ≤ 30 mm
h−1), whereas it is 0.69 in the clinical ESR range (ESR >
30 mm h−1).
In the clinical setting, the ESR value of 30 mm h−1 is ac-
cepted as the cut-off for further investigation of infec-
tion.8,12,33 Therefore, we analysed our results both in the
whole dynamic range and also in the healthy and clinical
ranges. The correlation coefficient value in the normal ESR
range (0–30 mm h−1) is higher than that in the clinical ESR
Fig. 2 Aggregation indices calculated for the ESR measurement. n = 4 whole blood samples were tested using an Westergren ESR analyzer as
reference. (a) Transmitted signal intensity of the 4 samples recorded for 120 s using the microfluidic system. Goodness of fit, R2, between the
Westergren ESR and microfluidic ESR for (b) AI1 and (c) AI2 measured at increasing analysis times.
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range (>30 mm h−1). Although the correlation is weakened at
high ESR values, it does not pose a problem for the micro-
fluidic ESR system; since quantitative analysis is not required
for high ESR values in clinics. It suffices to identify the pa-
tients with high ESR values who are directed to specialists for
further analysis.
Precision and repeatability
After finding the linear equations that are used to calculate
ESR values from the AI2 measurements, the performance of
the microfluidic system was further evaluated. First, the pre-
cision of the microfluidic system was tested. For the preci-
sion tests, whole blood samples of 5 volunteers were first
measured with the Westergren method as 4, 21, 33, 54, and
100 mm h−1 (Fig. 4, x-axis). Following the conventional mea-
surements using the Westergren analyzer, each sample was
tested five times with the microfluidic system. The mean
values were 4, 21, 36, 46, and 78 mm h−1, respectively (Fig. 4,
y-axis). The standard deviation for each sample was calcu-
lated as 0.82, 0, 1.41, 5.03, and 1.64 mm h−1, respectively,
and shown as error bars in Fig. 4.
The measurements for the precision tests (Fig. 4) were re-
peated immediately one after the other, determining how
precise the measurements were within a very short period of
time. It is also important to look at the device performance
when there is a delay between the repetitive measurements.
Clinically, this is a significant concern, since the time gap be-
tween the blood sampling from the patient and testing in a
central laboratory varies from a few minutes to 4–5 hours.
This time gap shows variability not only between different
health centers but also within the same center. Therefore, it
is critical to test the repeatability of the system for samples
stored in blood sampling tubes for different times. For these
repeatability tests, two whole blood samples were chosen
with ESR values of 30 mm h−1 and 57 mm h−1 (W 30). The
samples were tested four times using the microfluidic system
over the course of 3 h, with 1 h delay between measurements.
As shown in Fig. 5b, for the sample with an ESR value of 30
mm h−1, the mean and the standard deviation of the four
measurements were 27.3 mm h−1 and 1.3 mm h−1, respec-
tively. For the 57 mm h−1 ESR sample, the mean and the
standard deviation were 52 mm h−1 and 2.9 mm h−1, respec-
tively. These results demonstrate that aggregation dynamics
of the erythrocytes are not affected with the 3 h storage of
the sample at room temperature.
Simultaneous ESR measurement and EA monitoring
Another major goal of this study is to demonstrate the corre-
spondence between the erythrocyte aggregation dynamics
and the optical transmission signal obtained from the porta-
ble microfluidic system. Fig. 6 shows the transmitted signal
intensity for the pre-processed blood sample filled within car-
tridge-2. The intensity–time curve includes both the disaggre-
gation phase (lasting for 15 s) and the aggregation phase
(lasting for 6 min). The blood sample was diluted (plasma-
free and suspended in PBS) to observe individual cells in the
shallow section. Then, 150 kDa dextran was added to induce
cell aggregation. Cartridge-2 was uniquely designed such that
(i) the cells in the shallow section can be monitored under a
microscope, (ii) the diluted sample gives satisfactory optical
transmission in the deep section, and (iii) the disaggregating
shear rates on the cells in both cartridge sections are the
same (see the Microfluidic measurement system section). 200
μl of the prepared blood sample was introduced into the car-
tridge. After rigorous mixing of the sample, which achieves
complete disaggregation as shown in Fig. 6 at time: 0 min,
Fig. 3 Comparison of the microfluidic system test results with the
gold standard Westergren method. n = 70 whole blood samples tested
using the Westergren ESR analyzer (y-axis) and the microfluidic system
(x-axis). Goodness of fit, R2, is 0.86 using linear regression analysis. In-
set: n = 35 blood samples in the normal ESR range (0–30 mm h−1), R2
of 0.79; n = 35 blood samples in the clinical ESR range (>30 mm h−1),
R2 of 0.69.
Fig. 4 Precision tests for the microfluidic system. n = 5 whole blood
samples tested. Samples were first tested with the Westergren ESR
analyzer (x-axis), and five times with the microfluidic system (y-axis).
Error bars denote 2 standard deviations (SD).
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the cells were left intact for 6 min. During that time, the opti-
cally transmitted signal was measured in the deep section,
and the erythrocyte aggregation process was video-recorded
at the same time. In addition to the intensity–time curve,
Fig. 6 gives time-lapse images taken from the recorded video.
The time at which each image was taken has one-to-one cor-
respondence with the intensity–time curve. At time: 0 min,
the mixing was stopped, and the transmitted signal intensity
was at its minimum when the cells were completely
disaggregated. As time proceeded, the cells were shown to ag-
gregate. At the beginning, aggregation was rapid and erythro-
cytes form bridges with the neighbouring cells. At time: 3
min, even though there are individual cells, most of the cells
were clustered as aggregates. After time: 3 min, aggregates
Fig. 5 Repeatability performance of the microfluidic system. (a) n = 2 whole blood samples with the ESR (W 30 min) values of 30 mm h−1 (black
square) and 57 mm h−1 (red circle) tested with the microfluidic system. Samples were first tested with the Westergren ESR analyzer, and then four
times with the microfluidic system with 1 h delay between consecutive tests. (b) The mean (27.25 mm h−1) and SD (1.26 mm h−1) for the sample
with ESR of 30 mm h−1 and the mean (52 mm h−1) and SD (2.83 mm h−1) for the sample with ESR of 57 mm h−1.
Fig. 6 Simultaneous ESR measurement and EA monitoring with the microfluidic system. 200 μl of a pre-processed blood sample was filled into
cartridge-2 and optical measurement taken from the deep section for 6 min after complete disaggregation. The erythrocyte aggregation process
was monitored in the shallow section for 6 min simultaneously as the ESR measurement. A plot showing the transmitted signal intensity measured
for 6 min, and the time-lapse images of the aggregation process starting with complete disaggregation (t: 0 min).
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proceeded at a much lower rate which is also confirmed by
the intensity–time curve.
Although there are some studies in the literature that dis-
cuss the correlation between erythrocyte aggregation and sed-
imentation, none of these studies show the process in real-
time. Also, a drawback of the commercial devices in the mar-
ket is their potential incapability for succeeding complete dis-
aggregation at the beginning of the assay.55,61 The micros-
copy observations we made using cartridge-2 explains the
correlation between erythrocyte aggregation and light inten-
sity change. At complete disaggregation, each cell becomes a
scattering center,16 and their collective scattering results in
less signal transmitting through the blood sample, leading to
the lowest transmission intensity. During the aggregation
phase, the total area of the scattering centers decreases. This
leads to more light passing through the microchannel,
resulting in an increase of the transmitted signal intensity.
In whole blood, erythrocytes cannot be thought of as inde-
pendent from the other blood constituents. There are many
internal factors that affect the rate of erythrocyte sedimenta-
tion measured by the Westergren method. These include the
hematocrit level, plasma protein concentration, erythrocyte
deformability, temperature, plasma viscosity and den-
sity.16,55,61,62 Some of these factors affecting the sedimenta-
tion might not affect the aggregation dynamics. For example,
plasma viscosity has a major effect on the settling time of
erythrocytes in the conventional system, but it has a minor
effect in our system due to the fast measurement of the ag-
gregation mechanism in a very small region of the cartridge.
In contrast, erythrocyte deformability has a relatively minor
effect in the conventional system, but it changes the aggre-
gability of erythrocytes resulting in a major effect in our sys-
tem. Since the microfluidic system that we developed mea-
sures the rate of EA and use it to predict ESR, some of these
factors might be under or overestimated. This also explains
the correlation coefficient of R2 = 0.86.
On the other hand, there are several external factors
influencing ESR results obtained by the Westergren method.
These include (i) the initial sample volume in the tube, (ii)
tube vertical positioning, (iii) vibration, (iv) homogeneity of
the sample at the beginning of the assay, (v) delay between
venipuncture and measurement, and (vi) manual reading of
the result by the operator. Our portable microfluidic system
addresses all of these shortcomings of the conventional
method. (i) Measurement is performed at a single point
along the sample channel. Cartridge-1 requires 40 μl of a
sample to fill the channel. Deviation from this amount does
not affect the results as long as there is sample in front of
the sensor during the test. (ii) Erythrocyte aggregation is not
affected by the cartridge/analyzer orientation. (iii) The system
is vibration-proof; carrying the system in hand during the
measurement does not affect the results. (iv) Homogeneity of
the sample and complete disaggregation were ensured by
sample mixing at the beginning of the test cycle. However, in
the conventional assay, the operator should ensure sample
homogeneity before placing the tube into the analyzer. (v)
Since the system is portable and requires a very small sample
volume, the measurement can be carried out at the point-of-
care without any delay. (vi) The system is a truly sample-in re-
sult-out system, thus eliminates operator mistakes.
Conclusion
We have developed a portable microfluidic system that deter-
mines the erythrocyte sedimentation rate (ESR) from erythro-
cyte aggregation (EA). We experimentally showed the correla-
tion between the two physiological phenomena. We
explained the fundamental relationship between ESR and EA
using Stokes' law. Erythrocyte aggregates of large cell clusters
lead to a higher sedimentation velocity. This direct relation-
ship was used for rapid measurement of ESR. The micro-
fluidic system uses 40 μl of whole blood and completes the
test in 2 min. We measured the aggregation index from the
transmitted signal passing through the sample, which relates
ESR to EA. The results were compared with the conventional
Westergren method and the microfluidic system showed high
repeatability. We also showed the real-time observation of
erythrocytes during ESR measurement using a unique car-
tridge geometry. Simultaneous ESR measurement and EA
monitoring demonstrated one-to-one correspondence be-
tween the optical signal and the erythrocyte disaggregation
and aggregation phases. The system was shown to eliminate
the drawbacks of the Westergren method (operator-related
problems such as tube shaking, sample volume, tube posi-
tioning, and result reading). The presented microfluidic sys-
tem is a low sample volume requiring, low-cost, and portable
system for ultrafast ESR measurement that can be used at
point-of-care.
Acknowledgements
The authors acknowledge support from The Scientific and
Technological Research Council of Turkey (TUBITAK project
no. 213S127).
References
1 A. Grzybowski and J. Sak, Clin. Dermatol., 2011, 29, 697–703.
2 A. L. F. Westergren, Acta Med. Scand., 1921, 54, 247–282.
3 M. R. Cheema and S. M. Ismaeel, Clin. Interventions Aging,
2016, 11, 185–188.
4 R. L. Wong and J. H. Korn, Am. J. Med., 1986, 80, 959–964.
5 J. H. C. Sox and M. H. Liang, Ann. Intern. Med., 1986, 104,
515–523.
6 F. Wolfe and K. Michaud, J. Rheumatol., 1994, 21, 1227–1237.
7 S. M. Helfgott and R. I. Kieval, Arthritis Rheum., 1996, 39,
304–307.
8 M. Plebani and E. Piva, Am. J. Clin. Pathol., 2002, 117,
621–626.
9 A. S. Singh, V. Atam, B. E. Yathish, L. Das and S. Koonwar,
J. Neurosci. Rural Pract., 2014, 5, 40–45.
10 M. B. Andresdottir, N. Sigfusson, H. Sigvaldason and V.
Gudnason, Am. J. Epidemiol., 2003, 158, 844–851.















































4690 | Lab Chip, 2016, 16, 4682–4690 This journal is © The Royal Society of Chemistry 2016
11 J.-E. Johansson, T. Sigurdsson, L. Holmberg and R.
Bergstrom, Cancer, 1992, 70, 1556–1563.
12 S. E. Bedell and B. T. Bush, Am. J. Med., 1985, 78, 1001–1009.
13 B. S. Bull, M. Caswell, E. Ernst, J. M. Jou, A. Kallner, J. A.
Koepke, S. M. Lewis, G. D. O. Lowe, M. W. Rampling and J.
Stuart, J. Clin. Pathol., 1993, 46, 198–203.
14 D. Brooks, in Blood Cells, Rheology, and Aging, Springer,
1988, pp. 158–162.
15 B. Neu and H. J. Meiselman, Handbook of Hemorheology and
Hemodynamics, 2007, vol. 69, p. 114.
16 O. Baskurt, B. Neu and H. J. Meiselman, Red blood cell
aggregation, CRC Press, 2011.
17 H. Amini, W. Lee and D. Di Carlo, Lab Chip, 2014, 14,
2739–2761.
18 S. Chien, The red blood cell, 1975, vol. 2, pp. 1031–1133.
19 G. Tomaiuolo, M. Barra, V. Preziosi, A. Cassinese, B. Rotoli
and S. Guido, Lab Chip, 2011, 11, 449–454.
20 K.-M. Jan and S. Chien, J. Gen. Physiol., 1973, 61, 638–654.
21 G. Nash and H. Meiselman, Biorheology, 1984, 22, 73–84.
22 M. Rampling, H. Meiselman, B. Neu and O. Baskurt,
Biorheology, 2004, 41, 91–112.
23 N. Maeda, K. Imaizumi, M. Sekiya and T. Shiga, Biochim.
Biophys. Acta, Biomembr., 1984, 776, 151–158.
24 N. Maeda and T. Shiga, Biochim. Biophys. Acta, Gen. Subj.,
1985, 843, 128–136.
25 M. Boynard and J. Lelievre, Biorheology, 1989, 27, 39–46.
26 N. Maeda, M. Seike, T. Nakajima, Y. Izumida, M. Sekiya and
T. Shiga, Biochim. Biophys. Acta, Biomembr., 1990, 1022,
72–78.
27 G. Barshtein, I. Tamir and S. Yedgar, Eur. Biophys. J.,
1998, 27, 177–181.
28 B. Neu, R. Wenby and H. J. Meiselman, Biophys. J., 2008, 95,
3059–3065.
29 S. Shin, J.-H. Nam, J.-X. Hou and J.-S. Suh, Clin. Hemorheol.
Microcirc., 2009, 42, 117–125.
30 H.-J. Lim, Y.-J. Lee, J.-H. Nam, S. Chung and S. Shin,
J. Biomech., 2010, 43, 546–550.
31 O. K. Baskurt, M. Uyuklu, S. Ozdem and H. J. Meiselman,
Clin. Hemorheol. Microcirc., 2011, 47, 295–305.
32 O. K. Baskurt, A. Temiz and H. J. Meiselman, J. Lab. Clin.
Med., 1997, 130, 183–190.
33 O. K. Baskurt and H. J. Meiselman, Clin. Hemorheol.
Microcirc., 2013, 53, 23–37.
34 B. S. Bull and J. D. Brailsford, Blood, 1972, 40, 550–559.
35 D. Pieragalli, S. Forconi, M. Guerrini, A. Acciavatti, C.
Galigani, C. Del Bigo and T. Di Perri, Ric. Clin. Lab.,
1984, 15, 79–86.
36 O. K. Baskurt, H. Meiselman and E. Kayar, Clin. Hemorheol.
Microcirc., 1998, 19, 307–314.
37 M. Hardeman, J. Dobbe and C. Ince, Clin. Hemorheol.
Microcirc., 2001, 25, 1–11.
38 O. K. Baskurt, M. Uyuklu, M. R. Hardeman and H. J.
Meiselman, J. Biomed. Opt., 2009, 14, 054044.
39 O. K. Baskurt, M. Uyuklu, P. Ulker, M. Cengiz, N. Nemeth, T.
Alexy, S. Shin, M. R. Hardeman and H. J. Meiselman, Clin.
Hemorheol. Microcirc., 2009, 43, 283–298.
40 E. Hysi, R. K. Saha and M. C. Kolios, Biomed. Opt. Express,
2012, 3, 2326–2338.
41 S. Chen, G. Barshtein, B. Gavish, Y. Mahler and S. Yedgar,
Clin. Hemorheol. Microcirc., 1994, 14, 497–508.
42 S. Chen, B. Gavish, S. Zhang, Y. Mahler and S. Yedgar,
Biorheology, 1995, 32, 487–496.
43 G. Barshtein, D. Wajnblum and S. Yedgar, Biophys. J.,
2000, 78, 2470–2474.
44 S. Jayavanth and M. Singh, ITBM-RBM, 2004, 25, 67–74.
45 B. Rappaz, P. Marquet, E. Cuche, Y. Emery, C. Depeursinge
and P. Magistretti, Opt. Express, 2005, 13, 9361–9373.
46 S. Mavandadi, S. Feng, F. Yu, S. Dimitrov, K. Nielsen-Saines,
W. R. Prescott and A. Ozcan, PLoS One, 2012, 7, e46192.
47 T. Kim, R. Zhou, M. Mir, S. D. Babacan, P. S. Carney, L. L.
Goddard and G. Popescu, Nat. Photonics, 2014, 8, 256–263.
48 D. Dannhauser, D. Rossi, F. Causa, P. Memmolo, A. Finizio,
T. Wriedt, J. Hellmers, Y. Eremin, P. Ferraro and P. Netti,
Lab Chip, 2015, 15, 3278–3285.
49 L. Miccio, P. Memmolo, F. Merola, P. A. Netti and P. Ferraro,
Nat. Commun., 2015, 6, 6502.
50 C. D. Chin, V. Linder and S. K. Sia, Lab Chip, 2012, 12,
2118–2134.
51 C. van Berkel, J. D. Gwyer, S. Deane, N. Green, J. Holloway,
V. Hollis and H. Morgan, Lab Chip, 2011, 11, 1249–1255.
52 M. Plebani, S. De Toni, M. C. Sanzari, D. Bernardi and E.
Stockreiter, Am. J. Clin. Pathol., 1998, 110, 334–340.
53 N. Boğdaycioğlu, F. M. Yilmaz, S. Sezer and E. Oğuz, J. Clin.
Lab. Anal., 2015, 29, 397–404.
54 G. G. Stokes, On the effect of the internal friction of fluids on
the motion of pendulums, Pitt Press, 1851.
55 M. R. Hardeman, M. Levitus, A. Pelliccia and A. A. Bouman,
Scand. J. Clin. Lab. Invest., 2010, 70, 21–25.
56 J. Curvers, J. Kooren, M. Laan, E. van Lierop, D. Van de
Kerkhof, V. Scharnhorst and M. Herruer, Am. J. Clin. Pathol.,
2010, 134, 653–660.
57 W. C. Hinds, Aerosol technology: properties, behavior, and
measurement of airborne particles, John Wiley & Sons, 2012.
58 E. Berthier, E. W. Young and D. Beebe, Lab Chip, 2012, 12,
1224–1237.
59 C. Macosko, Rheology: Principles, Measurements, and
Applications, Wiley-VCH, New York, 1994.
60 M. Li, D. N. Ku and C. R. Forest, Lab Chip, 2012, 12, 1355–1362.
61 M. R. Hardeman, M. Levitus, A. Pelliccia and A. A. Bouman,
Scand. J. Clin. Lab. Invest., 2010, 70, 26–32.
62 Y. Zheng, J. Nguyen, Y. Wei and Y. Sun, Lab Chip, 2013, 13,
2464–2483.
Lab on a ChipPaper
Pu
bl
is
he
d 
on
 1
0 
N
ov
em
be
r 
20
16
. D
ow
nl
oa
de
d 
by
 B
ilk
en
t U
ni
ve
rs
ity
 o
n 
12
/2
3/
20
18
 1
1:
36
:2
7 
A
M
. 
View Article Online
